| Institution: | 1. Instituto de Investigaciones Biomedicas “Alberto Sols” CSIC-Universidad Autónoma de Madrid, Departamento de Biologia del Cáncer, Arturo Duperier 4, 28029 Madrid, Spain;2. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain;3. Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08907 L’Hospitalet, Barcelona, Catalonia, Spain;1. Department of Internal Medicine, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06032 USA;2. School of Medicine, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06032 USA;3. Department of Genetics/Developmental Biology, University of Connecticut Health Center, 400 Farmington Ave., Farmington, CT 06032 USA;4. Department of Dermatology, University of Connecticut Health Center, 21 South Rd, Farmington, CT 06032 USA;1. Institute of Biology and Medical Genetics of the First Faculty of Medicine and General University Hospital in Prague, Charles University in Prague, Czech Republic;2. Institute of Forensic Medicine and Toxicology of the First Faculty of Medicine and General University Hospital in Prague, Charles University in Prague, Czech Republic;3. Institute of Criminalistics Prague, Police of the Czech Republic, Czech Republic;1. Department of Genetics, La Trobe University, Melbourne, VIC, Australia;2. Victoria Police Forensic Services Department, Melbourne, VIC, Australia;3. Forensic Genetics Unit, Institute of Legal Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain;1. Laboratory of Chromatin and Cancer Epigenetics, Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India;2. Department of Surgical Oncology, IRCH, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India |
